Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
221 CHF | +1,01% | -0,50% | -9,61% |
26/04 | Roche's medicijn tegen longkanker Alecensa goedgekeurd in EU | MT |
25/04 | Scholz belooft verdere steun voor farmaceutische industrie | DP |
Filters: Beursproducten
Beurs
Noord-Amerika
Zuid-Amerika
Europa
Afrika
Midden-Oosten
Azië
Oceanië
Centraal-Amerika
Uitgever
Product
Type
Looptijd
Alleen beschikbaar voor producten met hefboomwerking
Hefboom / Elasticiteit
Beursproducten
Mnemo | Type | Financieringsniveau | Looptijd | Elasticiteit | Delta | Pariteit | Koers | Uitgever | ||
---|---|---|---|---|---|---|---|---|---|---|
CALL
| CALL | 600 CHF | 20-12-2024 | 7.32x | 0.019 | 40 | 0.027 0.001 |
UBS
| ||
CALL
| CALL | 600 CHF | 24-12-2025 | 6.43x | 0.024 | 40 | 0.03 0.012 |
UBS
| ||
CALL
| CALL | 560 € | 21-06-2024 | 7.2x | 0.024 | 10 | 0.151 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 550 CHF | 20-12-2024 | 7.77x | 0.02 | 40 | 0.027 0.001 |
UBS
| ||
CALL
| CALL | 550 CHF | 24-12-2025 | 6.66x | 0.028 | 40 | 0.032 0.014 |
UBS
| ||
CALL
| CALL | 500 CHF | 20-12-2024 | 10.05x | 0.01 | 40 | 0.01 0.001 |
UBS
| ||
CALL
| CALL | 500 CHF | 21-06-2024 | 11.11x | 0.006 | 40 | 0.005 0.001 |
UBS
| ||
CALL
| CALL | 500 CHF | 19-12-2025 | 6.93x | 0.033 | 40 | 0.035 0.017 |
UBS
| ||
CALL
| CALL | 500 € | 21-06-2024 | 6.15x | 0.056 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 500 € | 21-06-2024 | 7.81x | 0.026 | 10 | 0.151 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 500 € | 20-12-2024 | 8.27x | 0.022 | 10 | 0,01 EUR |
Goldman Sachs
| ||
CALL
| CALL | 480 € | 21-06-2024 | 6.33x | 0.057 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 470 € | 21-06-2024 | 6.43x | 0.058 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 460 € | 21-06-2024 | 6.53x | 0.059 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 450 CHF | 20-12-2024 | 11.77x | 0.009 | 40 | 0.005 0.003 |
UBS
| ||
CALL
| CALL | 450 CHF | 21-06-2024 | 12.28x | 0.007 | 40 | 0.005 0.001 |
UBS
| ||
CALL
| CALL | 450 CHF | 19-12-2025 | 7.22x | 0.04 | 40 | 0.04 0.022 |
UBS
| ||
CALL
| CALL | 450 € | 21-06-2024 | 0 | 10 | 0,001 EUR |
Société Générale
| |||
CALL
| CALL | 450 € | 21-06-2024 | 6.65x | 0.06 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 450 € | 20-12-2024 | 0 | 10 | 0,001 EUR |
Société Générale
| |||
CALL
| CALL | 450 € | 21-06-2024 | 8.53x | 0.028 | 10 | 0.151 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 450 € | 20-12-2024 | 9.05x | 0.024 | 10 | 0.112 0.012 |
Goldman Sachs
| ||
CALL
| CALL | 440 € | 21-06-2024 | 6.77x | 0.061 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 440 CHF | 19-12-2025 | 7.31x | 0.042 | 40 | 0.041 0.023 |
UBS
| ||
CALL
| CALL | 440 € | 20-12-2024 | 6.68x | 0.065 | 100 | 0,004 EUR |
Morgan Stanley
| ||
CALL
| CALL | 430 € | 21-06-2024 | 6.9x | 0.063 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 425 € | 21-06-2024 | 6.97x | 0.063 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 420 € | 21-06-2024 | 7.04x | 0.064 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 420 CHF | 20-12-2024 | 9.65x | 0.026 | 40 | 0.027 0.003 |
UBS
| ||
CALL
| CALL | 420 € | 20-12-2024 | 6.96x | 0.068 | 100 | 0,004 EUR |
Morgan Stanley
| ||
CALL
| CALL | 415 € | 21-06-2024 | 7.12x | 0.065 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 410 € | 21-06-2024 | 7.2x | 0.065 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 405 € | 21-06-2024 | 7.28x | 0.066 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 400 CHF | 20-12-2024 | 10.1x | 0.028 | 40 | 0.027 0.004 |
UBS
| ||
CALL
| CALL | 400 CHF | 21-06-2024 | 10.22x | 0.026 | 40 | 0.027 0.001 |
UBS
| ||
CALL
| CALL | 400 CHF | 19-12-2025 | 7.5x | 0.054 | 40 | 0.049 0.031 |
UBS
| ||
CALL
| CALL | 400 € | 21-06-2024 | 11.27x | 0.018 | 10 | 0,001 EUR |
Société Générale
| ||
CALL
| CALL | 400 € | 21-06-2024 | 9.58x | 0.032 | 10 | 0.151 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 400 € | 21-06-2024 | 7.37x | 0.067 | 100 | 0,001 EUR |
Morgan Stanley
| ||
CALL
| CALL | 400 € | 20-12-2024 | 10.42x | 0.025 | 10 | 0,02 EUR |
Société Générale
| ||